Impact of Point-of-Care Decision Support Tool on Laboratory Screening for Comorbidities in Children with Obesity.
Tara K KaufmanNatalie GentileSeema KumarMarian HalleBrian A LynchValeria CristianiKaren FischerRajeev ChaudhryPublished in: Children (Basel, Switzerland) (2020)
The implementation of a point-of-care decision support tool was not associated with improvement in screening rates for dyslipidemia, fatty liver disease, and type 2 diabetes for children with obesity. Further strategies are needed to improve rates of screening for obesity-related comorbid conditions in children with obesity.